title: Death possibly associated with interferon use in a patient with chronic hepatitis.
authors.forename: Tanil
authors.initials: T
authors.lastname: Kendirli
authors.forename: Erol
authors.initials: E
authors.lastname: Kismet
authors.forename: Erkan
authors.initials: E
authors.lastname: Demirkaya
authors.forename: Halil Ibrahim
authors.initials: HI
authors.lastname: Aydin
authors.forename: Vural
authors.initials: V
authors.lastname: Kesik
authors.forename: Vedat
authors.initials: V
authors.lastname: Köseoğlu
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002675:Child, Preschool; D017809:Fatal Outcome; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins